Medicare Enrolled
Dr. Frank Lai, M.D.
Urology Physician · Mountain View, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lai
Dr. Frank Lai is an urology physician in Mountain View, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lai performed 119,895 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lai received a total of $14,327 from 69 pharmaceutical and/or device companies across 494 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in CA
$14,327 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗119,895
Medicare services
Top 1% in CA for urology physician
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
108,750 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $18 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,089 | $108 | $239 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
952 | $3 | $30 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
790 | $11 | $51 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
464 | $11 | $196 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
313 | $108 | $337 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
311 | $44 | $259 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
263 | $14 | $57 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
252 | $80 | $200 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
242 | $231 | $512 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 189 | $135 | $419 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
164 | $141 | $363 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
154 | $121 | $326 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
110 | $70 | $155 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
94 | $114 | $356 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
80 | $384 | $751 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
68 | $77 | $211 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
65 | $963 | $3,000 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
62 | $86 | $273 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
55 | $24 | $48 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
53 | $22 | $43 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
53 | $162 | $319 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
48 | $33 | $88 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
42 | $45 | $322 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
41 | $177 | $556 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
33 | $63 | $200 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
33 | $358 | $1,250 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
29 | $66 | $877 |
| Complicated insertion of bladder tube | 28 | $145 | $284 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $156 | $431 |
| Bladder and urethra dilation with endoscope A procedure to widen the bladder and urethra using a thin, flexible tube with a camera. The endoscope allows the provider to visually guide the dilation process. |
24 | $168 | $677 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $100 | $342 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
20 | $319 | $604 |
| New patient office visit, complex (60-74 min) | 19 | $189 | $451 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
18 | $659 | $3,000 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
13 | $1,385 | $3,500 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
13 | $0 | $75 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
12 | $130 | $579 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
95.6% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,327
Total received (2018-2024)
Avg $2,047/year across 7 years
Top 15% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
494
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,890
2023
$2,927
2022
$3,173
2021
$1,637
2020
$917
2019
$1,995
2018
$1,787
Payments by company (2024)
Edap Technomed Inc
$690
Dendreon Pharmaceuticals LLC
$435
Sumitomo Pharma America, Inc.
$351
Astellas Pharma US Inc
$89
Bayer Healthcare Pharmaceuticals Inc.
$44
BLUEWIND MEDICAL
$39
IMMUNITYBIO, INC.
$34
UROGEN PHARMA, INC.
$26
Axonics, Inc.
$24
ABBVIE INC.
$23
ACCORD HEALTHCARE, INC.
$23
Medtronic, Inc.
$21
Ferring Pharmaceuticals Inc.
$20
Janssen Biotech, Inc.
$20
COLOPLAST CORP
$19
PROGENICS PHARMACEUTICALS, INC.
$17
BIOTISSUE HOLDINGS INC.
$15
Top 3 companies account for 78.1% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$1,677
Astellas Pharma US Inc
$1,474
Sumitomo Pharma America, Inc.
$1,045
Dendreon Pharmaceuticals LLC
$895
NeoTract Inc.
$851
Edap Technomed Inc
$690
AngioDynamics, Inc.
$667
Janssen Biotech, Inc.
$617
UROVANT SCIENCES INC
$602
PFIZER INC.
$553
Boston Scientific Corporation
$520
Antares Pharma, Inc.
$431
Amgen Inc.
$311
EDAP TECHNOMED INC
$311
ABBVIE INC.
$278
180 Medical, Inc.
$235
Bayer HealthCare Pharmaceuticals Inc.
$192
Myovant Sciences Inc.
$192
Agiliti Surgical, Inc.
$151
Coloplast Corp
$135
MEDIVATION FIELD SOLUTIONS LLC
$127
Ferring Pharmaceuticals Inc.
$127
AbbVie Inc.
$122
Myriad Genetic Laboratories, Inc.
$121
Takeda Pharmaceuticals U.S.A., Inc.
$101
Bayer Healthcare Pharmaceuticals Inc.
$100
AbbVie, Inc.
$98
PROCEPT BioRobotics Corporation
$98
UroGen Pharma, Inc.
$96
COLOPLAST CORP
$94
C. R. BARD, INC. & SUBSIDIARIES
$92
TherapeuticsMD, Inc.
$84
Progenics Pharmaceuticals, Inc.
$73
Merck Sharp & Dohme LLC
$72
AstraZeneca Pharmaceuticals LP
$67
Merck Sharp & Dohme Corporation
$65
Hollister Incorporated
$63
ACCORD HEALTHCARE, INC.
$58
Endo Pharmaceuticals Inc.
$58
Intuitive Surgical, Inc.
$55
Retrophin, Inc.
$51
Medtronic, Inc.
$41
Travere Therapeutics, Inc.
$40
BLUEWIND MEDICAL
$39
BIOTISSUE HOLDINGS, INC.
$38
C. R. Bard, Inc. & Subsidiaries
$37
Axonics, Inc.
$36
Celgene Corporation
$35
IMMUNITYBIO, INC.
$34
Allergan, Inc.
$30
UROGEN PHARMA, INC.
$26
Rigel Pharmaceuticals, Inc.
$25
Laborie Medical Technologies Corp.
$25
Olympus America Inc.
$23
NxThera, Inc.
$22
DENTSPLY IH Inc.
$21
Alexion Pharmaceuticals, Inc.
$19
Mission Pharmacal Company
$18
Smith+Nephew, Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$17
Profound Medical Corp.
$16
Dornier MedTech America, Inc
$16
Clarus Therapeutics Inc.
$16
Blue Earth Diagnostics Limited
$16
SRS Medical Systems, Inc.
$15
Photocure Inc
$15
E.R. Squibb & Sons, L.L.C.
$15
BIOTISSUE HOLDINGS INC.
$15
MAYNE PHARMA COMMERCIAL LLC
$11
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CLENPIQ · CURE CATHETER · CURE HYDRO · Cysview · DARZALEX · Da Vinci Surgical System · ERLEADA · EVENITY · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL THERAPIES · GENERAL - BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENTLECATH · General - Kidney Stone Disease · IMVEXXY · INTERSTIM · Infyna Chic · JATENZO · JELMYTO · KANJINTI · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LYRICA · LithoVue · Lithotripters & Accessories · LoFric · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NANOKNIFE · NEOX · NOCDURNA · Nubeqa · ORGOVYX · Onli · PENILE & TESTICULAR RECONSTRUCTN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · REVI · ROCHESTER MAGIC3 · Revlimid · Rezum · SKYLITE · SOLIRIS · SPEEDICATH · STRAVIX · SUTENT · Sonablate · TOVIAZ · Tavalisse · Titan · Tulsa-Pro · UROLIFT · Uribel · UroCuff · UroLift · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
138
County median income
$159,674
Nearest hospital to ZIP centroid (approximate)
EL CAMINO HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lai is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lai experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Lai performed 108,750 testosterone undecanoate injection (aveed) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lai receive payments from pharmaceutical companies?
Yes. Dr. Lai received a total of $14,327 from 69 companies across 494 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lai's costs compare to other urology physicians in Mountain View?
Dr. Lai's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Mountain View
Browse urology physicians in Mountain View ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology